Special Situations Fund International Ltd Deerfield is 10% at DUSA PHARMACEUTICALS INC (DUSA). They have made 15 open-market trades across 6 companies since 2006, most recently 2011-09-26.
CIK 0001354397
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
9 open-market purchases totalling $41.8M since 2006, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TLON.OB | SELL · 10b5-1 | 2011-09-26 | 2011-09-28 | $1.00 | $8K | N/A | N/A | N/A |
| DUSA | SELL | 2011-03-15 | 2011-03-17 | $4.46 | $4.0M | N/A | N/A | N/A |
| NXTM | SELL | 2009-09-29 | 2009-10-01 | $7.07 | $26K | -11.6% | -2.1% | -2.1% |
| NGSX | SELL | 2009-07-08 | 2009-07-10 | $5.92 | $140K | N/A | N/A | N/A |
| NGSX | SELL | 2009-07-06 | 2009-07-08 | $5.93 | $323K | N/A | N/A | N/A |
| NGSX | SELL | 2009-06-22 | 2009-06-25 | $6.24 | $520K | N/A | N/A | N/A |
| NXTM | SELL | 2009-06-12 | 2009-06-19 | $5.96 | $161K | -11.6% | -2.1% | -2.1% |
| NTMD | BUY | 2009-04-24 | 2009-04-27 | $0.86 | $39.6M | N/A | N/A | N/A |
| NTMD | BUY | 2008-07-28 | 2008-07-30 | $1.00 | $51K | N/A | N/A | N/A |
| NTMD | BUY | 2008-07-15 | 2008-07-17 | $1.00 | $2K | N/A | N/A | N/A |
| NTMD | BUY | 2008-07-08 | 2008-07-09 | $0.96 | $41K | N/A | N/A | N/A |
| NTMD | BUY | 2008-05-15 | 2008-05-19 | $1.15 | $124K | N/A | N/A | N/A |
| ISTA | BUY | 2006-05-18 | 2006-05-22 | $5.68 | $868K | N/A | N/A | N/A |
| DVAX | BUY | 2006-05-15 | 2006-05-17 | $5.50 | $133K | -2.9% | -1.7% | -1.7% |
| DVAX | BUY | 2006-03-07 | 2006-03-09 | $6.01 | $197K | -2.9% | -1.7% | -1.7% |
| DVAX | BUY | 2006-03-03 | 2006-03-07 | $5.90 | $703K | -2.9% | -1.7% | -1.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Shares reported on the most recent Form 4, priced at the 2011-09-28 close. 5 holdings could not be priced and are excluded from the total.